Recs

103

You’d Be Stupid to Buy These Stocks

Now is an absolutely ridiculous time to buy small-cap stocks.

You'd be a dope to snap up shares of companies like AgFeed (Nasdaq: FEED  ) , Human Genome Sciences (Nasdaq: HGSI  ) , Cell Therapeutics (Nasdaq: CTIC  ) , and Conseco (NYSE: CNO  ) -- all of which are up more than 500% since March's market low.

Or at least, that's what you might be thinking, now that the small-cap Russell 2000 Index is outpacing the S&P 500 by more than 15 percentage points. Even The Wall Street Journal predicts that the small-cap rally is set to come screeching to a halt. 

But don't be duped ...
Just because many small-cap stocks have seen a huge increase in the last few months doesn't mean you should avoid all of them.

First, no one accurately called the market's bottom in March, so it's dubious whether anyone now has the ability to call a top just a few months later.

Second, the Russell 2000's sharp rise has largely been driven by the speculative bidding-up of penny stocks (stocks with share prices below $5). Many companies whose share prices were above $5 per share in March have not shared in the astronomically high returns -- including companies whose fundamentals have actually improved year to date.

This trend isn't unique to small caps. In fact, S&P 500 stocks whose prices fell below $5 during this bear market -- including Ford (NYSE: F  ) , Genworth Financial (NYSE: GNW  ) , and Fifth Third Bancorp (Nasdaq: FITB  ) -- have been some of the highest gainers in that index.

But this still raises the question: Why have penny stocks risen quicker than non-penny stocks?

Pain, baby, pain
Behavioral psychologists refer to the "pain of paying" -- the mental barrier we face when parting with our cash. The higher the cost, the higher the barrier.

For investors focusing on share price (instead of, say, underlying company quality), it's less painful to toss an extra dime per share into purchasing a penny stock (even if this is twice what the stock was trading for the day before) than it is to toss in an extra $5 per share for a stock that was trading for more than $100 a share the day before.

Rational? Certainly not.

However, this speculative irrationality presents the savvy small-cap investor with a great opportunity.

How to cash in on small-cap movement
There are two ways you can profit from the rush to penny stocks:

  1. Join the rush and gamble your hard-earned money by trying to guess which penny stock might rise next.
  2. Invest in small-cap companies whose fundamentals have been improving, but which are still undervalued by the market.

As much as we'd all love to have a stock shoot up more than 5,000% in just a few months -- as penny-stock micro-cap Diedrich Coffee recently did -- at the end of the day, the first tactic is nothing but a risky crapshoot.

So though your inclination might be to go for the gusto to make up for losses, the second option is really the only way to set yourself up with a portfolio that will grow your wealth at above-average rates over long periods of time.

After all, the best small caps have the ability to consistently outperform -- which is why they have consistently been the top-performing stocks of the past four years.

Time to be smart
One stock I think you'd be smart to buy right now -- one that I have my eye on, and which the team at Motley Fool Hidden Gems recently bought -- is Brink's Home Security.

The company has a market cap of just $1.4 billion, and it boasts a clean balance sheet with $83 million in cash and zero debt. Best of all, it's currently trading for just eight times the team's calculation of steady-state cash flow.

The stock has risen significantly since the end of 2008 -- but the team still expects market-beating returns over the next two to three years, with very little risk. 

You can browse through their whole investment thesis, and examine their in-depth valuation of this company and many others, completely free with a trial membership to Hidden Gems. Click here for more information.

Already subscribe to Hidden Gems? Log in at the top of this page.

Adam J. Wiederman owns no shares of the companies mentioned above. The Motley Fool owns shares of Brink's Home Security, a Motley Fool Hidden Gems recommendation. The Fool's disclosure policy is anything but stupid.


Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On August 24, 2009, at 12:38 PM, ozzfan1317 wrote:

    Ford Actually could turn out to be a good investment. Depends on how much market share they gain and the amount of trust that their Bankrupt competitors have lost.

  • Report this Comment On August 24, 2009, at 1:06 PM, jc73ny wrote:

    If you really think about it, the list should be a lot bigger if the writer is comparing March lows, but it doesn't mean you shouldn't buy some of them. Stocks like BAC was $3.14 in March and Citi was $1.03 also, now BAC is about $18, and Citi is almost $5., Are they good buys at this price since they didn't make this list ?

  • Report this Comment On August 24, 2009, at 9:06 PM, 1971Mach1 wrote:

    HGSI was $0.50 in March, and now Over $17. It was ruled out by 90% of the analysts before their Phase III trial report - just because there was no new Lupus drug for more than 30 years.

    Economy will start growing again, and that's what people believe. There eill be some bumpy roads ahead, overall, the stock prices will continue their up trend.

    Being pessimistic is one thing, saying people who buy these stock are stupid without some hard facts is just as stupid.

    I do not believe HGSI will come out with a bad report this November, and predict it will gain FDA approval next year for the Lupus drug. $36 in 16-24 months - a bargain even at today's price.

  • Report this Comment On August 24, 2009, at 10:21 PM, RainierMan wrote:

    I would be careful before you go leaving people with the impression that CTIC has a great future.

  • Report this Comment On August 25, 2009, at 11:05 AM, Ibeatmykids wrote:

    Of course small caps are up 15% more. Small caps have higher betas than your BRKs and MMM and DOWs.

  • Report this Comment On August 25, 2009, at 11:10 AM, tensaibakabon wrote:

    the day this guy names HGSI it shoots up 2 bucks!! His prediction ofr HGSi is totally wrong and baseless. I wonder who is dope now!

  • Report this Comment On August 28, 2009, at 9:18 PM, kayakingkarl wrote:

    Next time read the article before commenting.

  • Report this Comment On September 08, 2009, at 8:27 PM, EnigmaDude wrote:

    Just because many small-cap stocks have seen a huge increase in the last few months doesn't mean you should avoid all of them.

    Exactly - that is why you should take a closer look at what is driving them up.

Add your comment.

Compare Brokers

Fool Disclosure

DocumentId: 969965, ~/Articles/ArticleHandler.aspx, 2/10/2012 5:33:00 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 7 hours ago Sponsored by:
DOW 12,890.46 6.51 0.05%
S&P 500 1,351.95 1.99 0.15%
NASD 2,927.23 11.37 0.39%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

2/9/2012 4:00 PM
FITB $13.52 Down -0.09 -0.66%
Fifth Third Bancor… CAPS Rating: **
GNW $8.91 Up +0.01 +0.11%
Genworth Financial… CAPS Rating: ***
HGSI $10.00 Up +0.12 +1.21%
Human Genome Scien… CAPS Rating: **
FEED $0.39 Down +0.00 +0.00%
AgFeed Industries,… CAPS Rating: ***
CNO $7.23 Down -0.16 -2.17%
Conseco, Inc. CAPS Rating: ***
CTIC $1.10 Down -0.02 -1.79%
Cell Therapeutics,… CAPS Rating: **
F $12.69 Down -0.15 -1.17%
Ford CAPS Rating: ****

Advertisement